国家组织药品集中采购和使用试点扩围江西中选结果25个药品自2019年12月20日起在全省执行，第二批国家组织药品集中采购和使用江西中选结果32个药品自2020年4月11日起在全省执行。现将截至2020年7月31日采购进度及有关情况通报如下。
一、扩围中选品种采购情况
（一）采购数量。截至7月31日，25个中选药品的31个品规在全省12个联盟地区采购总数量为32657.96万片/支/袋；按药品统计，最高为厄贝沙坦75mg的5375.02万片，最低为培美曲塞500mg的0.29万支。
（二）采购金额。31个品规在全省12个联盟地区采购总金额为29792.86万元，占同品规药品采购金额的59.02%。按药品统计，最高为氯吡格雷75mg的6621.67万元，最低为赖诺普利10mg的9.65万元。
（三）完成进度。31个品规的全省采购总数量占约定采购总量的比例为155.74%，27个品规完成全省约定采购数量，3个品规完成超过75%，1个品规完成超过50%。
（四）中选药占比。31个品规的全省采购总数量占同品规下所有药品采购总数量的比例为87.64%；按药品统计，最高为培美曲塞100mg的98.89%，最低为替诺福韦300mg的70.59%。
（五）网上配送率。31个品规的全省采购订单总数量为46117.55万片/支/袋，企业网上配送数量为34822.05万片/支/袋，总体配送率为75.51%。按药品统计，有3个品规的配送率低于60%，分别为瑞舒伐他汀5mg的39.39%、替诺福韦300mg的43.59%和瑞舒伐他汀10mg的55.64%。
二、第二批中选品种采购情况
（一）采购数量。32个药品的36个品规在全省12个联盟地区采购总数量为13641.63万片/支/袋；按药品统计，最高为阿卡波糖50mg的5688.91万粒，最低为安立生坦5mg的0.58万片。
（二）采购金额。36个品规的全省采购总金额为5045.66万元，占同品规药品采购金额的65.13%。按药品统计，最高为注射用紫杉醇（白蛋白结合型）100mg的1408.99万元，最低为比索洛尔2.5mg的2.30万元。
（三）完成进度。36个品规的全省采购总数量占约定采购总量的比例为108.21%，16个品规完成全省约定采购数量，15个品规完成进度大于50%。
（四）中选药占比。36个品规的全省采购总数量占同品规下所有药品采购总数量的比例为87.26%；有3个品规的占比低于规定比例，分别是阿莫西林0.5g、阿奇霉素0.25g和克林霉素0.15g。
（五）网上配送率。36个品规的全省采购订单总数量为17332.76万片/支/袋，企业网上配送数量为1405.46万片/支/袋，总体配送率为81.09%。有6个品规的配送率低于60%，分别为阿莫西林0.5g、比索洛尔2.5mg、奥美沙坦酯20mg、格列美脲2mg、美洛昔康7.5mg和曲美他嗪35mg。
三、中选品种回款情况
截至7月底,采购平台共有各供货企业和医疗机构的明细账单39848份，两批次国家带量采购中选药品在全省12个采购联盟的账单总金额为34838.52万元，回款（含预付）总金额为33452.12万元，回款比例为96.02%。
附表1:国家组织药品集中采购和使用试点扩围江西中选药品采购情况（截至7月31日）
| 药品 | 采购数量 （万片/支/袋） | 采购金额 （万元） | 完成进度 | 中选药占比 | 网上配送率 |
| 阿托伐他汀10mg | 2277.5 | 273.3 | 186.39% | 89.79% | 75.49% |
| 阿托伐他汀20mg | 3096.7 | 632.6 | 164.62% | 75.08% | 68.32% |
| 瑞舒伐他汀10mg | 2431.1 | 554.3 | 242.75% | 89.34% | 55.64% |
| 瑞舒伐他汀5mg | 746.1 | 97.6 | 158.71% | 82.65% | 39.39% |
| 氯吡格雷75mg | 2602.6 | 6621.7 | 196.34% | 96.10% | 93.75% |
| 厄贝沙坦75mg | 5375.0 | 1041.9 | 119.17% | 97.43% | 89.83% |
| 氨氯地平5mg | 5220.5 | 313.2 | 180.03% | 80.87% | 68.96% |
| 恩替卡韦0.5mg | 2819.1 | 774.2 | 139.38% | 87.16% | 77.18% |
| 艾司西酞普兰10mg | 236.6 | 997.8 | 194.19% | 80.57% | 93.48% |
| 帕罗西汀20mg | 236.2 | 368.0 | 136.36% | 92.17% | 94.94% |
| 奥氮平10mg | 325.1 | 2024.7 | 116.19% | 91.88% | 99.70% |
| 奥氮平5mg | 413.2 | 1475.9 | 180.84% | 90.48% | 97.99% |
| 头孢呋辛250mg | 477.1 | 230.8 | 91.46% | 95.01% | 94.23% |
| 利培酮1mg | 1662.8 | 199.5 | 102.96% | 88.58% | 84.84% |
| 吉非替尼250mg | 11.5 | 631.5 | 103.73% | 93.83% | 95.52% |
| 福辛普利10mg | 51.6 | 42.4 | 71.91% | 97.12% | 80.99% |
| 厄贝沙坦氢氯噻嗪150mg+12.5mg | 899.7 | 917.7 | 171.97% | 89.97% | 94.51% |
| 赖诺普利10mg | 41.9 | 9.7 | 202.24% | 94.41% | 84.86% |
| 替诺福韦300mg | 188.5 | 71.5 | 217.40% | 70.59% | 43.59% |
| 氯沙坦100mg | 51.0 | 91.5 | 225.35% | 94.15% | 77.99% |
| 氯沙坦50mg | 1310.8 | 1343.9 | 308.68% | 93.33% | 89.62% |
| 依那普利10mg | 856.4 | 478.0 | 165.29% | 92.33% | 93.13% |
| 依那普利5mg | 527.4 | 173.0 | 113.12% | 80.07% | 90.96% |
| 左乙拉西坦250mg | 161.5 | 386.5 | 816.23% | 91.28% | 91.53% |
| 伊马替尼100mg | 27.7 | 288.2 | 442.45% | 96.07% | 98.04% |
| 孟鲁司特10mg | 183.8 | 712.3 | 134.16% | 86.14% | 98.07% |
| 蒙脱石3g | 330.4 | 108.8 | 99.56% | 87.64% | 93.18% |
| 培美曲塞100mg | 0.9 | 745.1 | 163.81% | 98.89% | 100.00% |
| 培美曲塞500mg | 0.3 | 798.0 | 76.76% | 96.05% | 98.98% |
| 氟比洛芬酯50mg/5ml | 47.1 | 1034.9 | 112.39% | 84.47% | 94.98% |
| 右美托咪定0.2mg/2ml | 47.8 | 6354.3 | 349.75% | 95.80% | 98.66% |
| 总计 | 32657.96 | 29792.86 | 155.74% | 87.64% | 75.51% |
附表2:第二批国家组织药品集中采购江西中选药品采购情况（截至7月31日）
| 药品 | 采购数量 （万片/支/袋） | 采购金额 （万元） | 完成进度 | 中选药占比 | 网上配送率 |
| 阿比特龙口服常释剂型0.25g | 10.96 | 392.22 | 1404.62% | 98.49% | 88.50% |
| 阿德福韦酯口服常释剂型10mg | 153.92 | 138.53 | 279.10% | 90.34% | 90.46% |
| 阿卡波糖口服常释剂型50mg | 5688.91 | 1027.71 | 126.43% | 89.18% | 89.94% |
| 阿卡波糖口服常释剂型100mg | 106.39 | 32.66 | 51.60% | 84.26% | 74.30% |
| 阿莫西林口服常释剂型0.25g | 1779.84 | 118.36 | 143.99% | 80.53% | 96.01% |
| 阿莫西林口服常释剂型0.5g | 62.23 | 7.16 | 9.26% | 35.99% | 39.38% |
| 阿奇霉素口服常释剂型0.25g | 78.85 | 83.58 | 32.32% | 70.40% | 98.50% |
| 安立生坦片5mg | 0.58 | 11.58 | 275.71% | 99.52% | 94.10% |
| 奥美沙坦酯口服常释剂型20mg | 39.17 | 23.90 | 94.88% | 86.69% | 49.24% |
| 比索洛尔口服常释剂型2.5mg | 6.17 | 2.30 | 17.56% | 65.55% | 39.03% |
| 比索洛尔口服常释剂型5mg | 165.89 | 105.18 | 85.81% | 80.16% | 96.69% |
| 对乙酰氨基酚口服常释剂型0.5g | 64.31 | 3.59 | 85.10% | 92.84% | 91.89% |
| 多奈哌齐口服常释剂型5mg | 37.80 | 42.98 | 92.08% | 84.74% | 86.48% |
| 氟康唑口服常释剂型50mg | 60.77 | 17.12 | 56.29% | 87.21% | 96.25% |
| 福多司坦口服常释剂型0.2g | 219.48 | 138.55 | 62.25% | 88.67% | 89.02% |
| 格列美脲口服常释剂型2mg | 1130.42 | 87.42 | 103.77% | 91.03% | 44.79% |
| 甲硝唑口服常释剂型0.2g | 701.14 | 35.55 | 115.76% | 89.82% | 96.87% |
| 聚乙二醇口服散剂10g | 27.08 | 32.03 | 114.85% | 98.60% | 81.43% |
| 坎地沙坦酯口服常释剂型4mg | 383.46 | 104.08 | 50.15% | 88.93% | 99.45% |
| 克林霉素口服常释剂型0.15g | 27.26 | 2.73 | 48.11% | 73.02% | 93.87% |
| 铝碳酸镁咀嚼片0.5g | 222.22 | 57.78 | 147.05% | 98.86% | 97.85% |
| 美洛昔康口服常释剂型7.5mg | 64.20 | 17.24 | 97.61% | 87.13% | 46.76% |
| 莫西沙星口服常释剂型0.4g | 18.62 | 41.16 | 88.63% | 87.67% | 81.17% |
| 曲美他嗪缓释控释剂型35mg | 267.32 | 125.11 | 187.15% | 95.98% | 49.59% |
| 索利那新口服常释剂型5mg | 2.73 | 9.06 | 79.42% | 87.45% | 93.34% |
| 他达拉非片20mg | 2.04 | 96.04 | 221.95% | 94.73% | 95.25% |
| 特拉唑嗪口服常释剂型2mg | 127.26 | 61.54 | 88.56% | 86.34% | 95.89% |
| 替吉奥口服常释剂型20mg | 45.74 | 357.08 | 47.96% | 89.61% | 98.39% |
| 替吉奥口服常释剂型25mg | 28.52 | 264.17 | 69.22% | 89.73% | 99.10% |
| 头孢氨苄口服常释剂型0.25g | 171.68 | 14.62 | 100.66% | 87.38% | 80.63% |
| 头孢拉定口服常释剂型0.25g | 273.84 | 32.68 | 121.49% | 74.37% | 96.23% |
| 辛伐他汀口服常释剂型20mg | 1013.58 | 107.15 | 146.45% | 91.48% | 82.35% |
| 异烟肼口服常释剂型0.1g | 458.45 | 18.25 | 146.76% | 88.93% | 93.24% |
| 吲达帕胺口服常释剂型2.5mg | 135.89 | 9.44 | 82.59% | 94.90% | 93.62% |
| 紫杉醇（白蛋白结合型）100mg | 1.81 | 1408.99 | 221.78% | 96.60% | 95.60% |
| 左西替利嗪口服常释剂型5mg | 63.11 | 18.14 | 85.38% | 87.57% | 96.76% |
| 总计 | 13641.63 | 5045.66 | 108.21% | 87.26% | 81.09% |